Renaissance Technologies - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is and the CUSIP is 66987P300. A total of 16 filers reported holding NOVABAY PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$26
-23.5%
58,823
+30.9%
0.00%
Q2 2023$34
+6.2%
44,923
+139.9%
0.00%
Q1 2023$32
-5.9%
18,723
+7.5%
0.00%
Q4 2022$3417,4230.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 141,000$239,7000.00%
Addison Advisors LLC 4$70.00%
Blue Trust, Inc. 37$00.00%
Renaissance Technologies 18,723$320.00%
ROYAL BANK OF CANADA 15$00.00%
UBS Group AG 182$3090.00%
WealthPLAN Partners, LLC 1$20.00%
OSAIC HOLDINGS, INC. 37$630.00%
BANK OF AMERICA CORP /DE/ 86$1460.00%
WELLS FARGO & COMPANY/MN 10$170.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders